Maternal antibiotic prophylaxis during cesarean section has a limited impact on the infant gut microbiome.


Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 20 10 2023
revised: 09 05 2024
accepted: 09 07 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 15 8 2024
Statut: ppublish

Résumé

Pregnant women undergoing a cesarean section (CS) typically receive antibiotics prior to skin incision to prevent infections. To investigate if the timing of antibiotics influences the infant gut microbiome, we conducted a randomized controlled trial (NCT06030713) in women delivering via a scheduled CS who received antibiotics either before skin incision or after umbilical cord clamping. We performed a longitudinal analysis on 172 samples from 28 infants at 8 post-birth time points and a cross-sectional analysis at 1 month in 79 infants from 3 cohorts. Although no significant associations with bacterial composition, metabolic pathways, short-chain fatty acids, and bile acids were found, we observed subtle differences between the groups at the bacterial strain level and in the load of antibiotic resistance genes. Rather, feeding mode was a predominant and defining factor impacting infant microbial composition. In conclusion, antibiotic administration during CS has only limited effects on the early-life gut microbiome.

Identifiants

pubmed: 39146801
pii: S1931-3128(24)00268-3
doi: 10.1016/j.chom.2024.07.010
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bile Acids and Salts 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1444-1454.e6

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests T.d.M. has served as a speaker for Danone Nutricia Research and Mead Johnson. The funders had no role in study design, data analysis, data interpretation, writing of the manuscript, and the decision to publish.

Auteurs

Trishla Sinha (T)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: t.sinha@rug.nl.

Jelmer R Prins (JR)

Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Asier Fernández-Pato (A)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Marloes Kruk (M)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Thomas Dierikx (T)

Department of Medical Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands.

Tim de Meij (T)

Department of Paediatric Gastroenterology, Amsterdam UMC, Emma Children's Hospital, Amsterdam, the Netherlands.

Marjon de Boer (M)

Department of Obstetrics and Gynaecology, Reproduction and Development, Amsterdam UMC Locatie VUmc, Amsterdam, the Netherlands.

Jan Freark de Boer (JF)

Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Sicco Scherjon (S)

Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Alexander Kurilshikov (A)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Alexandra Zhernakova (A)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH